Parkinson Disease: all 4,583 studies

Page 17 of 46. Open to participants first (1,097), then studies with results posted, then the rest; newest registration first within each.

• Solifenacin Succinate (VESIcare) for the Treatment of Overactive Bladder in Parkinson's DiseaseCompletedNCT01018264Phase 4Results posted
• RECHARGE Sub-Study to the Implantable Systems Performance Registry (ISPR)CompletedNCT00998660Phase 4Results posted
• Deep Brain Stimulation (DBS) Frequency Effects on Gait in Parkinson's Disease(PD)CompletedNCT00993291Phase 1/2Results posted
• The Effects of the Rivastigmine Patch on Parkinson's Disease With Memory and/or Thinking ProblemsCompletedNCT00988117Phase 4Results posted
• Study to Compare the Effect of Ropinirole Prolonged Release Once-daily Versus Twice-dailyCompletedNCT00986245Phase 4Results posted
• Safety and Efficacy of CERE-120 in Subjects With Parkinson's DiseaseCompletedNCT00985517Phase 1/2Results posted
• 50 Hz Repetitive Transcranial Magnetic Stimulation (rTMS) for the Treatment of Parkinson's DiseaseCompletedNCT00977184Phase 1/2Results posted
• A Study To Evaluate The Safety And Efficacy Of IPX066 In Advanced Parkinson's Disease (ADVANCE-PD).CompletedNCT00974974Phase 3Results posted
• Repetitive Transcranial Magnetic Stimulation (rTMS) for the Treatment of Apathy in Parkinson's DiseaseCompletedNCT00955032Not applicableResults posted
• Cholinergic Augmentation in Frequently Falling Subjects With Parkinson's DiseaseCompletedNCT00912808Not applicableResults posted
• Safety, Tolerability and Efficacy Assessment of Dynacirc CR in Parkinson DiseaseCompletedNCT00909545Phase 2Results posted
• Amitiza in Constipation Associated With PD (Parkinson's Disease)CompletedNCT00908076Phase 4Results posted
• A Study To Evaluate The Safety And Efficacy Of IPX066 In Subjects With Parkinson's DiseaseCompletedNCT00880620Phase 3Results posted
• A Study to Compare Pharmacokinetics and Pharmacodynamics of IPX066 to Standard Carbidopa-LevodopaCompletedNCT00869791Phase 2Results posted
• Evaluation of Long-term Effect of Resonator Therapy on Parkinson's Disease (PD)CompletedNCT00862537Results posted
• Florbetapir F 18 PET Imaging of Beta-amyloid in Parkinson's Disease PatientsCompletedNCT00857532Phase 2Results posted
• Expiratory Muscle Training for Persons With Neurodegenerative DiseaseCompletedNCT00856518Phase 2/3Results posted
• Acute Effects of Preladenant (SCH 420814) on Dyskinesia and Parkinsonism in Levodopa Treated Participants (P05550)CompletedNCT00845000Phase 1Results posted
• Safety of Urate Elevation in Parkinson's DiseaseCompletedNCT00833690Phase 2Results posted
• Clinical Evaluation of Ropinirole Prolonged Release/Extended Release (PR/XR) Tablet for Adjunctive Therapy to L-dopa in Subjects With Advanced Parkinson's DiseaseCompletedNCT00823836Phase 3Results posted
• First Presentation of Parkinson Disease Patients to NeurologistCompletedNCT00802178Results posted
• Quantification of the Antidyskinetic Effect of Amantadine and Topiramate in Parkinson's DiseaseTerminatedNCT00794313Not applicableResults posted
• Effects of Aerobic Exercise in Parkinson's DiseaseCompletedNCT00784563Not applicableResults posted
• Study of Magnetic Fields for Treatment of Parkinson's DiseaseCompletedNCT00779155Phase 2Results posted
• Safety and Efficacy Study of NH004 Films for Relief of Sialorrhea Symptoms in Parkinson's Disease PatientsCompletedNCT00761137Phase 2Results posted
• Parkinson's Disease Isradipine Safety StudyCompletedNCT00753636Phase 2Results posted
• Transcranial Magnetic Stimulation to Treat Parkinson's DiseaseCompletedNCT00753519Phase 1/2Results posted
• Effects of Coenzyme Q10 (CoQ) in Parkinson DiseaseTerminatedNCT00740714Phase 3Results posted
• Lubiprostone as a Treatment for Constipation in Parkinson's DiseaseTerminatedNCT00669461Not applicableResults posted
• Treating H. Pylori in Parkinson's Patients With Motor FluctuationsTerminatedNCT00664209Phase 3Results posted
• Open Label Continuation Treatment Study With Levodopa-Carbidopa Intestinal Gel in Advanced Parkinson's DiseaseCompletedNCT00660673Phase 3Results posted
• Study of Efficacy, Safety and Tolerability of Levodopa-Carbidopa Intestinal Gel in Levodopa-Responsive Parkinson's SubjectsCompletedNCT00660387Phase 3Results posted
• A Study of Safety and Efficacy of Pimavanserin (ACP-103) in Patients With Parkinson's Disease PsychosisCompletedNCT00658567Phase 3Results posted
• Non-motor Symptoms (Depressive Symptoms) of Parkinson's Disease and Their Course Under Pramipexole TreatmentCompletedNCT00651183Results posted
• Long-term Extension Study Evaluating Extended Release Ropinirole XL (Formerly Referred to as Ropinirole CR) in Patients Who Already Completed Either Study 167 or 164CompletedNCT00650104Phase 3Results posted
• Namenda (Memantine) for Non-motor Symptoms in Parkinson's DiseaseCompletedNCT00646204Phase 4Results posted
• Carbidopa/Levodopa/Entacapone Versus Immediate Release (IR) Carbidopa/Levodopa on Non-motor Symptoms in Patients With Idiopathic Parkinson's Disease and Demonstrating Non-motor Symptoms of Wearing OffTerminatedNCT00642356Phase 4Results posted
• Trial of Xyrem for Excessive Daytime Sleepiness and Sleep Disturbance in Parkinson's Disease (PD)CompletedNCT00641186Phase 2Results posted
• Selegiline to Zelapar Switch Study in Parkinson Disease PatientsCompletedNCT00640159Phase 4Results posted
• An Open-label Continuation Study Evaluating the Long-term Safety of Extended Release Ropinirole XL (Formerly CR) in Parkinson''s DiseaseCompletedNCT00632736Phase 3Results posted
• Preliminary Study of Piclozotan in Patients With Motor Complications Associated With Parkinson's DiseaseCompletedNCT00623363Phase 2Results posted
• Long-term Safety of Rivastigmine Capsule and Patch in Patients With Mild to Moderately-severe Dementia Associated With Parkinson's Disease (PDD)CompletedNCT00623103Phase 3Results posted
• Special Survey on Parkinson's Disease Patients Treated Long-term Use of PramipexoleCompletedNCT00615914Results posted
• Intravenous Versus Inhalational Anesthesia in Parkinson's DiseaseTerminatedNCT00615472Not applicableResults posted
• Survey on PD Patients With Depressive SymptomsCompletedNCT00614575Results posted
• Special Survey on Parkinson's Disease (PD) Patients Without Concomitant Use of L-DopaCompletedNCT00613301Results posted
• Long-term Safety Study of Open-label Pramipexole Extended Release (ER) in Patients With Early Parkinson´s Disease (PD).CompletedNCT00601523Phase 3Results posted
• Transdermal Rotigotine User Surveillance StudyCompletedNCT00599339Results posted
• An Open-Label Extension Trial to Assess the Safety of Long-Term Treatment of Rotigotine in Early-Stage Parkinson's DiseaseCompletedNCT00599196Phase 3Results posted
• A Trial of Neupro® (Rotigotine Transdermal Patch) in Patients With Parkinson's Disease Undergoing SurgeryCompletedNCT00594464Phase 4Results posted
• An Open-Label Extension Trial to Assess the Safety of Long-Term Treatment of Rotigotine in Advance-Stage Parkinson's DiseaseCompletedNCT00594386Phase 3Results posted
• An Open-Label Extension Trial to Assess the Safety of Long-Term Treatment of Rotigotine in Early-Stage Parkinson's Disease.CompletedNCT00594165Phase 3Results posted
• Safety and Tolerability Trial of Switching From Ropinirole to RotigotineCompletedNCT00593606Phase 3Results posted
• The Effect of Exercise on Individuals With Parkinson's DiseaseCompletedNCT00591344Not applicableResults posted
• Parcopa Versus Carbidopa-levodopa in a Single Dose Cross-over Comparison StudyCompletedNCT00590122Phase 4Results posted
• Long-term Safety Study of Open-label Pramipexole ER in Patients With Advanced PDCompletedNCT00577460Phase 3Results posted
• Assessment of Perampanel (E2007) on Synaptic Dopamine in Mild-moderate PD Patients: A Pilot Study With [^123I]-IBZM SPECTTerminatedNCT00566462Phase 2Results posted
• A 12-week Study of Pramipexole Extended Release (ER) in Patients With Parkinson's Disease (PD), Followed by a 52-week Long-term Treatment PeriodCompletedNCT00560508Phase 2/3Results posted
• Overnight Switch Trial From Pramipexole IR to Pramipexole ER in Patients With Early Parkinson DiseaseCompletedNCT00558025Phase 3Results posted
• A Study of the Safety and Tolerability of Pimavanserin (ACP-103) in Patients With Parkinson's Disease PsychosisCompletedNCT00550238Phase 3Results posted
• Augmenting Effects of L-DOPS With Carbidopa and EntacaponeTerminatedNCT00547911Phase 1/2Results posted
• A Placebo-controlled Study for SPM 962 in Early Parkinson's Disease PatientsCompletedNCT00537485Phase 2/3Results posted
• Follow Up Safety Study of SCH 420814 in Subjects With Parkinson's Disease (P05175)CompletedNCT00537017Phase 2Results posted
• Methylphenidate for the Treatment of Gait Impairment in Parkinson's DiseaseCompletedNCT00526630Phase 4Results posted
• Trial to Assess Parkinson's Disease (PD) Symptom Control to Four Doses of Rotigotine in a Transdermal PatchCompletedNCT00522379Phase 3Results posted
• Long-term Extension of RECOVER- Long-term Effect of the 24h Transdermal Delivery of Rotigotine in Subjects With Idiopathic Parkinson's DiseaseTerminatedNCT00519532Phase 3Results posted
• An Open-Label Extension Trial to Assess the Safety and Tolerability of Long Term Treatment of Rotigotine in Subjects With Idiopathic Parkinson's DiseaseCompletedNCT00505687Phase 3Results posted
• Evaluation of the Long-term Safety, Tolerability, and Efficacy of Perampanel (E2007) as an Adjunctive Therapy in Levodopa Treated Parkinson's Disease Subjects With Motor FluctuationsTerminatedNCT00505622Phase 3Results posted
• An Open-Label Extension Trial to Assess the Safety of Long-Term Treatment of Rotigotine in Advanced-Stage Parkinson's DiseaseCompletedNCT00501969Phase 3Results posted
• Cognitive Benefits of Treating Sleep Apnea in Parkinson's DiseaseCompletedNCT00492115Not applicableResults posted
• Safety/Efficacy of Tigan® to Control Nausea/Vomiting Experienced During Apokyn® Initiation and TreatmentCompletedNCT00489255Phase 4Results posted
• REQUIP (Ropinirole Hydrochloride) IR Long-Term Phase 4 StudyCompletedNCT00485069Phase 4Results posted
• Efficacy, Safety, Tolerability of Pramipexol ER Versus Pramipexol IR Versus Placebo in Early PD PatientsCompletedNCT00479401Phase 3Results posted
• A Study of the Safety and Efficacy of Pimavanserin (ACP-103) in Patients With Parkinson's Disease PsychosisCompletedNCT00477672Phase 3Results posted
• Randomized Evaluation of the 24-Hour Coverage: Efficacy of RotigotineCompletedNCT00474058Phase 3Results posted
• Developing Objective Measures of Levodopa Induced Dyskinesia: (Study 1)CompletedNCT00467597Results posted
• Pivotal Study in Advanced Parkinsons Disease PatientsCompletedNCT00466167Phase 3Results posted
• Impact of Switching to Continuous Release Dopamine AgonistsCompletedNCT00465452Phase 3Results posted
• Coping With Depression in Parkinson's DiseaseCompletedNCT00464464Not applicableResults posted
• NET-PD LS-1 Creatine in Parkinson's DiseaseTerminatedNCT00449865Phase 3Results posted
• Efficacy of Orally Disintegrating Selegiline in Parkinson's Patients Experiencing Adverse Effects With Dopamine AgonistsCompletedNCT00443872Phase 4Results posted
• Study on the Tolerability of Duloxetine in Depressed Patients With Parkinson's DiseaseCompletedNCT00437125Phase 4Results posted
• Clinical Evaluation of Ropinirole PR/XR Tablets in Monotherapy for Parkinson's Disease (PD)CompletedNCT00434304Phase 2Results posted
• A Study of E2007 In Patients With Parkinson's DiseaseTerminatedNCT00427011Phase 2Results posted
• Dyskinesia in Parkinson's Disease (Study P04501)CompletedNCT00406029Phase 2Results posted
• A Randomized, Double-blind, Active (Pramipexole 0.5 mg Tid) and Placebo Controlled, Study of Pramipexole Given 0.5 mg and 0.75 mg Bid Over 12-week Treatment in Early Parkinson's Disease (PD) PatientsCompletedNCT00402233Phase 4Results posted
• Double-Blind, Multicenter, Sham Surgery Controlled Study of CERE-120 in Subjects With Idiopathic Parkinson's DiseaseCompletedNCT00400634Phase 2Results posted
• Efficacy of Levodopa/Carbidopa/Entacapone vs Levodopa/Carbidopa in Parkinson's Disease Patients With Early Wearing-offCompletedNCT00391898Phase 4Results posted
• A Comparison of an Implanted Neuroprosthesis With Sensory Training for Improving Airway Protection in Chronic DysphagiaCompletedNCT00376506Phase 2Results posted
• Efficacy, Safety, and Tolerability of E2007 in Levodopa Treated Parkinson's Disease Patients With Motor FluctuationsCompletedNCT00368108Phase 3Results posted
• Safety/Efficacy Study of Levodopa-Carbidopa Intestinal Gel in Parkinson's SubjectsCompletedNCT00360568Phase 3Results posted
• A Study of E2007 as an Adjunctive Therapy in Levodopa Treated Parkinson's Disease Patients With Motor FluctuationsTerminatedNCT00360412Phase 3Results posted
• Efficacy, Safety and Tolerability of E2007 in Levodopa Treated Parkinson's Disease Patients With Motor FluctuationsTerminatedNCT00360308Phase 3Results posted
• Effects of Deep Brain Stimulation on Motor, Mood, and Cognitive Symptoms in Parkinson's DiseaseCompletedNCT00360009Not applicableResults posted
• Study of Efficacy, Safety and Tolerability of Levodopa-Carbidopa Intestinal Gel in Levodopa-Responsive Parkinson's SubjectsCompletedNCT00357994Phase 3Results posted
• Masked Faces in Parkinson Disease: Mechanism and TreatmentCompletedNCT00350402Phase 2Results posted
• Levodopa-Carbidopa Intestinal Gel Open-Label Study in Advanced Parkinson's DiseaseCompletedNCT00335153Phase 3Results posted
• Treatment of Insomnia in Patients With Parkinson's Disease: A Multi-site, Placebo-controlled Study of EszopicloneCompletedNCT00324896Phase 3Results posted
• Study of (Mirapex) Pramipexole for the Early Treatment of Parkinsons Disease (PD)CompletedNCT00321854Phase 4Results posted
• Laser Light Cues for Gait Freezing in Parkinson's DiseaseCompletedNCT00320242Not applicableResults posted

← Parkinson Disease overview